R. Minciu

MINIMALLY INVASIVE PROSTATE CANCER DIAGNOSIS BY GLUTHATIONE S-TRANSFERASE P 1 (GSTP 1 ) GENE METHYLATION ANALYSIS IN SERUM SPECIMENS

M. Puiu, R. Dumache, V. Dumitrașcu, 2011 .

Intravesical prostatic protrusion can be a predicting factor for the treatment outcome in patients with lower urinary tract symptoms due to benign prostatic obstruction treated with tamsulosin.

M. Botoca, A. Cumpănaş, R. Minciu, 2013, Urology.

Retinoic acid receptor β2 (RARβ2): nonivasive biomarker for distinguishing malignant versus benign prostate lesions from bodily fluids.

R. Bardan, M. Puiu, A. Tudor, 2012, Chirurgia.

Cytologic diagnosis of transitional cell carcinoma of the urinary bladder. Comparison with endoscopical and pathological findings on 538 cases.

M. Botoca, M. Raica, R. Minciu, 1997, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

Early detection of prostate cancer from body fluids using DNA promoter methylation

M. Puiu, R. Dumache, B. Bumbăcilă, 2010 .

Correlation between histopathological form and the degree of neuroendocrine differentiations in prostate cancer.

M. Raica, O. Mederle, R. Minciu, 2011, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

Molecular Detection of Prostate Cancer by Methylation-Specific Polymerase Chain Reaction from Urine Specimens

M. Puiu, S. Popescu, R. Dumache, 2013 .

Super-pulse thulium fiber versus high power holmium lasers. What about temperature?

M. Botoca, O. Traxer, S. Doizi, 2019, European Urology Supplements.

Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.

R. Dumache, A. Rogobete, D. Ionescu, 2016, Clinical laboratory.